We warmly congratulate Professor Wenbo Liu, Associate Dean of the College of Chemistry and Molecular Sciences at Wuhan University, on the recent publication of his collaborative research in Nature Communications, a prestigious journal in the Nature family.

This outstanding work on catalyst-controlled stereodivergent synthesis of polysubstituted alkenes represents a significant advance in modern catalytic chemistry, particularly in the rational control of molecular geometry and stereochemistry—an area of great importance for pharmaceutical synthesis.

Professor Liu serves as the Chief Scientific Advisor of Hiray Pharma Solutions Ltd.， His deep academic insight, combined with a strong understanding of industrial translation, provides invaluable guidance to our R&D team.

Under Professor Liu’s leadership and mentorship, we are confident that Hiray Pharma will continue to optimize the manufacturing processes of Orforglipron API and its key intermediates, achieving higher quality, greater robustness, and lower production costs, while maintaining the highest standards of safety and compliance.

We believe that the close integration of frontier academic research and industrial innovation is essential to advancing pharmaceutical technology—and ultimately, to improving human health.

Once again, congratulations on this remarkable scientific achievement.